Johan Lof - RaySearch Laboratories CEO and Presidentident, Member of the Board
| RSLBF Stock | USD 26.74 2.74 11.42% |
CEO
Mr. Johan Lof has served as Chief Executive Officer, President and Member of the Board of Directors of Raysearch Laboratories AB since 2000. He is also Founder of the Company. In addition, he is Chairman of the Board of RaySearch Americas Inc., RaySearch UK Ltd., Vinstandelsstitelsen RayFoundation and Venture Cap Sweden. He holds MS degree in Engineering Physics from the Royal Institute of Technology and a Doctorate of Philosophy degree from the Department of Medical Radiation Physics at the Department of OncologyPathology, Karolinska Institutet. As a doctoral student, he worked with mathematical models for optimization of radiation therapy and also developed the prototype for ORBIT. since 2000.
| Age | 54 |
| Tenure | 25 years |
| Phone | 46 8 51 05 30 00 |
| Web | https://www.raysearchlabs.com |
RaySearch Laboratories Management Efficiency
RaySearch Laboratories' management efficiency ratios could be used to measure how well RaySearch Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.RaySearch Laboratories AB has accumulated 13.74 M in total debt with debt to equity ratio (D/E) of 0.8, which is about average as compared to similar companies. RaySearch Laboratories has a current ratio of 1.11, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist RaySearch Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, RaySearch Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RaySearch Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RaySearch to invest in growth at high rates of return. When we think about RaySearch Laboratories' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 5 records | CEO Age | ||
| Ramy Farid | Schrodinger | 59 | |
| Jeffrey Tangney | Doximity | 52 | |
| Roy Schoenberg | American Well Corp | 51 | |
| Peter Arduini | GE HealthCare Technologies | 60 | |
| Peter Gassner | Veeva Systems Class | 60 | |
Management Performance
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 |
RaySearch Laboratories Leadership Team
Elected by the shareholders, the RaySearch Laboratories' board of directors comprises two types of representatives: RaySearch Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RaySearch. The board's role is to monitor RaySearch Laboratories' management team and ensure that shareholders' interests are well served. RaySearch Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RaySearch Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henrik Bergentoft, Chief Officer | ||
| Peter Kemlin, Director of Sales and Marketing | ||
| Johan Lof, CEO and Presidentident, Member of the Board | ||
| MBA CMD, Pres Americas | ||
| Kjell Eriksson, Chief Science Officer | ||
| Petra Jansson, General Counsel | ||
| Fredrik Lofman, Head Learning |
RaySearch Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is RaySearch Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Current Valuation | 237.19 M | |||
| Shares Outstanding | 25.83 M | |||
| Shares Owned By Insiders | 4.00 % | |||
| Shares Owned By Institutions | 55.61 % | |||
| Price To Earning | 31.16 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 3.02 X |
Currently Active Assets on Macroaxis
Other Information on Investing in RaySearch Pink Sheet
RaySearch Laboratories financial ratios help investors to determine whether RaySearch Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RaySearch with respect to the benefits of owning RaySearch Laboratories security.